| Nome |
# |
|
Immunologia dei trapianti e trapianto di cellule staminali ematopoietiche, file 88b647dd-3216-462b-8aea-388d21f616e0
|
448
|
|
A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging Therapeutics, file 3728b3e8-6405-4be8-880d-8ad2b8dac200
|
295
|
|
Vacuolization of hematopoietic precursors: an enigma with multiple etiologies, file 71808682-4662-4464-bcee-69ecda1baa0d
|
127
|
|
Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols, file af2056a3-6e4c-4bcb-a7f0-9c42270e3c53
|
113
|
|
Copper Deficiency, file e2debba5-b71f-4296-917a-f817251719ef
|
93
|
|
Aplastic anemia: quo vadis?, file 9cb49f19-330d-48ae-a484-90a36a67414f
|
63
|
|
A study of Telomerase Reverse Transcriptase rare variants in myeloid neoplasia, file d57e858d-413b-41d5-99e1-612b84db2557
|
63
|
|
Recruitment of MLL1 complex is essential for SETBP1 to induce myeloid transformation, file 9394332b-40b9-405d-aa71-341649633fcc
|
58
|
|
Monoclonal IgM gammopathy in adult acquired pure red cell aplasia: culprit or innocent bystander?, file b41d077b-3c23-408e-9a33-54d45c1ee14e
|
54
|
|
T-cell large granular lymphocytic leukemia associated with inclusion body myositis, file 6f231323-6dd6-4614-9d55-46e7de76f0ac
|
51
|
|
How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms, file 6b6c026a-7e45-45ad-b688-848aa8667be7
|
41
|
|
Personalized risk schemes and machine learning to empower genomic prognostication models in myelodysplastic syndromes, file 9f608a6b-6909-40d5-ab22-0a0c6a120c78
|
41
|
|
LGL Clonal Expansion and Unexplained Cytopenia: Two Clues Don't Make an Evidence, file b041043c-c43e-4191-84ee-8263ae1e05d5
|
40
|
|
UBA1 Screening in Sweet Syndrome With Hematological Neoplasms Reveals a Novel Association Between VEXAS and Chronic Myelomonocytic Leukemia, file 83c4b9cf-7caa-4e1c-a6eb-392a23586159
|
39
|
|
Current Opinions on the Clinical Utility of Ravulizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria, file e110679b-072d-417e-a8dd-d689007147e5
|
38
|
|
Comprehensive transcriptomic analysis of VISTA in acute myeloid leukemia: insights into its prognostic value, file 2dfe6227-8ddb-4965-abad-64a1cfb9c143
|
36
|
|
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia, file dba632b0-9b83-47e0-8c71-932540b46ce2
|
35
|
|
Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemia, file 288c6742-7540-40b3-a369-9ad58084bf39
|
34
|
|
The Interactome between Metabolism and Gene Mutations in Myeloid Malignancies, file 4a91b400-b004-4f05-9b04-d101e5260af8
|
33
|
|
Novel invariant features of Good syndrome, file 863e3b1c-baf7-452d-8caa-ba27979772ad
|
25
|
|
Digging into the HLA pockets: A new association with acute leukaemias, file 898a54fc-df62-40c0-865d-5ee614ac6ee0
|
24
|
|
A Focus on Intermediate-Risk Acute Myeloid Leukemia: Sub-Classification Updates and Therapeutic Challenges, file d6118840-0efb-4dcb-b648-cd0275817240
|
24
|
|
The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood, file cdcc8556-f281-4d6f-843a-0cd7dc7a2fe2
|
22
|
|
Vitamin C Deficiency in Patients With Acute Myeloid Leukemia, file 87309ec8-cd96-4e12-a781-46dcdbab408d
|
17
|
|
A non-cytotoxic regimen of decitabine to treat refractory T-cell large granular lymphocytic leukemia, file 4274d1ec-64f8-4b2b-a5ae-c87db61ca72b
|
14
|
|
Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy, file 8faa58cd-2bb7-4b8e-aca4-aee4f82bf66f
|
14
|
|
'We cannot paint them all with the same brush': the need for a better definition of patients with myelodysplastic syndromes for clinical trial design, file b228051f-b5e9-4092-96f1-09be8648351d
|
13
|
|
Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond, file b27b0b97-2bab-4844-ba81-ec1c3dfbc934
|
13
|
|
Identification of i(X)(p10) as the sole molecular abnormality in atypical chronic myeloid leukemia evolved into acute myeloid leukemia, file e291c0d8-ce77-cddb-e053-3a05fe0aa144
|
13
|
|
Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia, file 6e77b26a-a0e6-4b03-8095-259ea5d23b39
|
12
|
|
Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia, file 1b650c9f-61bf-4362-88c2-36fc22661eea
|
11
|
|
Deciphering the Therapeutic Resistance in Acute Myeloid Leukemia, file 44abc89b-bf5a-4139-aaf9-f652618a0922
|
11
|
|
Is nature truly healing itself? Spontaneous remissions in Paroxysmal Nocturnal Hemoglobinuria, file 48ff9ddd-c7d1-45c8-8b5b-026fec73907f
|
11
|
|
Clinical and basic implications of dynamic T cell receptor clonotyping in hematopoietic cell transplantation, file c3b9bf0f-9cb5-43c9-a395-ff2687aa4074
|
11
|
|
Predictors of Early Thrombotic Events in Adult Patients with Acute Myeloid Leukemia: A Real-World Experience, file 47eac2e3-aee8-47a1-8934-17ed6f2c3fa8
|
10
|
|
Alternative Splicing in Myeloid Malignancies, file c35151f2-f4e1-4e4e-9acb-0a01a3d45a35
|
10
|
|
Molecular Targeted Therapy in Myelodysplastic Syndromes: New Options for Tailored Treatments, file 72904ee2-904c-48c4-908f-1f78a0de5654
|
9
|
|
Have we reached a molecular era in myelodysplastic syndromes?, file 86328140-40e6-4cc9-8286-45fbfeb75a75
|
9
|
|
Large Granular Lymphocytic Leukemia: From Immunopathogenesis to Treatment of Refractory Disease, file d46cffbd-02b8-4a7d-bc7e-cb36b72024fc
|
9
|
|
Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide, file dee53335-1e29-4468-ac25-d6de6f925c8f
|
9
|
|
The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia, file 30b4320e-d753-4181-bf67-2061024c713b
|
7
|
|
The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia, file 438fbfd2-5023-460b-be55-15ebf00f74d8
|
7
|
|
Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder, file 638442b2-8bb3-4fa6-99a7-6b5c237249a9
|
7
|
|
TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes, file 69fa57b2-9e18-4dc2-83d0-e7b64eefa680
|
7
|
|
Essential Thrombocythemia and Acquired von Willebrand Syndrome: The Shadowlands between Thrombosis and Bleeding, file 9c0eade5-d013-475d-b501-5183832f1b0c
|
7
|
|
Hepatitis C Infection Associated with Acquired Pure Red Cell Aplasia, file bf0603f0-7ada-4623-974f-1b26deb8c149
|
7
|
|
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants, file 1af3ad23-4b45-4d6f-bb60-f046ebf00437
|
6
|
|
The Renovated Face of EHA Classical Master Class: A Survey-based Evaluation on Behalf of the EHA Campus Working Group, file e561084f-f4ad-48e0-bd06-e54b15ee65b4
|
6
|
|
Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomes, file 0edde51a-cf1a-4bfa-b13e-38875836f703
|
5
|
|
From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression, file 21ded611-1506-454c-8c5a-5c991d18de48
|
4
|
|
The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disorders, file 48843646-faef-4a87-ad03-f10f4d31c0b9
|
4
|
|
Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML, file a242b000-cde0-4b75-b758-51de98d0e0df
|
4
|
|
Congenital Rhabdomyosarcoma: a different clinical presentation in two cases, file b44c9aea-18ff-4593-9560-226aec77940d
|
4
|
|
When Poisons Cure: The Case of Arsenic in Acute Promyelocytic Leukemia, file ded2ebf5-d3fd-4be7-9c05-6e6fe0490359
|
4
|
|
Recurrent Sweet's syndrome in a patient with multiple myeloma, file f3da3b09-ff69-4c4e-a63a-de37e86965dc
|
4
|
|
Demethylation and Up-Regulation of an oncogene after hypomethylating therapy, file e91a6820-d7d3-4ec2-9c4b-da4155f58c21
|
3
|
|
What are the considerations for the pharmacotherapeutic management of acute promyelocytic leukemia in children?, file 4670e781-678a-49ef-aa76-ae3102040a98
|
2
|
|
Early detection of IgH monoclonal rearrangenent in follicular spicules of the nose preceding multiple myeloma diagnosis. Case report and review of the literature, file e291c0d7-32d7-cddb-e053-3a05fe0aa144
|
2
|
|
Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting, file e54b27c6-ef44-4af4-8c8f-d9500bfe460e
|
2
|
|
Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial-mesenchymal transition pathways, file e9e3a3b6-8533-4ece-8d5f-4aaf880c1937
|
2
|
|
Applications and efficiency of flow cytometry for leukemia diagnostics, file ece5ebd9-946e-4bcf-bf20-dba568251fba
|
2
|
|
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria, file 58d86639-0b80-4e10-9f4b-4f8e8e5aecd9
|
1
|
|
Chronic Budd-Chiari syndrome in paroxysmal nocturnal haemoglobinuria, file 80575b8e-4fd3-473c-bf56-ceba82d627f3
|
1
|
|
Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia, file 97323e35-111a-49e4-bf68-2bdb85c6ef62
|
1
|
|
Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria, file a0d1a114-f3aa-4f74-8235-10e82378e421
|
1
|
|
Pegcetacoplan versus Eculizumab in PNH, file a59e3f0d-ef24-4675-bd05-c6799fa87e1a
|
1
|
| Totale |
2.094 |